Donate COVID-19 Plasma
If you have fully recovered from COVID-19, you may be able to help patients currently fighting the infection by donating your plasma.
Featured Topics
FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jun 12
NOW Health Group Inc. Voluntarily Recalls NOW Real Food ®Raw Macadamia Nuts Because of Possible Health Risk
Food & Beverages
Jun 12
Rusty’s Seafood Market Issues Allergy Alert on Undeclared Allergens (Fish, Crustacean, Shellfish, Eggs, Milk, Soy, and Wheat) in all “Captain Rusty’s Seafood Dips”
Food & Beverages
Jun 11
RONG SHING TRADING NY INC. of Brooklyn, NY is Recalling its 21.1oz (600g) of Xi Zhi Liang Fruit Jelly Cup
Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Rare Disease Therapy Development and Access Remain Top FDA Priorities During COVID-19
FDA’s work to advance treatments for rare diseases and helping ensure continuity of care for people with rare diseases remain top priorities during COVID-19.
Pandemic Challenges Highlight the Importance of the New Era of Smarter Food Safety
The FDA will release the New Era of Smarter Food Safety Blueprint in the coming weeks, outlining our plans over the next decade to create a safer food system.
Bringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic
During the COVID-19 pandemic FDA recognizes the public interest around expediting the development and availability of a number of potential treatment options.
Recently Published Guidances
Jun 08
Temporary Policy on Prescription Drug Marketing Act Requirements for Distribution of Drug Samples During the COVID-19 Public Health Emergency
Drugs
Jun 05
Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)
Medical Devices
Jun 04
Temporary Policy Regarding Preventive Controls and FSVP Food Supplier Verification Onsite Audit Requirements During the COVID-19 Public Health Emergency
Food & Beverages